Ionis Pharmaceuticals Inc annual earnings per share (EPS) for fiscal TTM was $-3.46, a decrease of 45.4% from $-2.38 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-3.46 | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.49 | $2.06 | $2.04 | $0.00 | $-0.72 | $-0.74 | $-0.33 | $-0.55 | $-0.65 | $-0.85 | $-0.62 | $1.58 | $-0.19 | $-0.13 | $-0.62 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.68 | $-0.93 | $-0.66 | $-0.95 | $-0.45 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More IONS metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All IONS financial statements → Interactive IONS charts →
About TickerBase · Data methodology & sources · Privacy · Terms